^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ondansetron intravenous
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Generic mfg.
Drug class:
Serotonin 3 receptor antagonist
Related drugs:
2ms
Dexamethasone-Ondansetron Combined with Diphenhydramine for Preventing Postoperative Nausea and Vomiting in Thoracoscopic lung surgery: A double blind randomized controlled trial (ChiCTR2500110881)
P=N/A, N=200, Not yet recruiting, Anesthesia and Surgery Center of West China Hospital Sichuan University; West China Hospital Sichuan University
New trial
|
dexamethasone injection • ondansetron intravenous
2ms
Comparison of Aprepitant and Ondansetron for Postoperative Nausea and Vomiting after Laparoscopic Cholecystectomy (ChiCTR2500108960)
P=N/A, N=310, Not yet recruiting, The First Affiliated Hospital with Nanjing Medical University; The First Affiliated Hospital with Nanjing Medical University
New trial
|
ondansetron intravenous
3ms
Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery (clinicaltrials.gov)
P=N/A, N=50, Recruiting, Ondokuz Mayıs University | Not yet recruiting --> Recruiting
Enrollment open
|
dexamethasone injection • ondansetron intravenous
3ms
The Effect of Superficial Cervical Block Application on Postoperative Opioid Consumption in Patients Undergoing Anterior Cervical Discectomy Surgery (clinicaltrials.gov)
P=N/A, N=60, Completed, Medipol University | Recruiting --> Completed | Trial completion date: Jun 2025 --> Sep 2025 | Trial primary completion date: Apr 2025 --> Aug 2025
Trial completion • Trial completion date • Trial primary completion date
|
ondansetron intravenous
3ms
Serratus Posterior Superior Plane Block for Postoperative Pain in Cardiac Surgery (clinicaltrials.gov)
P=N/A, N=50, Not yet recruiting, Ondokuz Mayıs University
New trial
|
dexamethasone injection • ondansetron intravenous
4ms
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting (clinicaltrials.gov)
P2/3, N=250, Recruiting, Montefiore Medical Center | Trial completion date: May 2025 --> Jun 2026 | Trial primary completion date: May 2025 --> Jun 2026
Trial completion date • Trial primary completion date
|
fosaprepitant • ondansetron intravenous
4ms
NELCER: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix (clinicaltrials.gov)
P3, N=348, Active, not recruiting, Tata Memorial Hospital | Recruiting --> Active, not recruiting
Enrollment closed
|
cisplatin • Viracept (nelfinavir) • ondansetron intravenous
5ms
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC) (clinicaltrials.gov)
P2, N=95, Recruiting, Helsinn Healthcare SA | Not yet recruiting --> Recruiting
Enrollment open
|
fosaprepitant • ondansetron intravenous
5ms
Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy (clinicaltrials.gov)
P=N/A, N=170, Recruiting, Tanta University | Trial completion date: Jul 2025 --> Mar 2026 | Trial primary completion date: Jul 2025 --> Mar 2026
Trial completion date • Trial primary completion date • Head-to-Head
|
ondansetron intravenous
5ms
PDPH - N/V: Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and Vomiting (clinicaltrials.gov)
P4, N=150, Completed, Minia University
New P4 trial
|
dexamethasone injection • ondansetron intravenous
7ms
Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis (clinicaltrials.gov)
P3, N=32, Terminated, Spectrum Health - Lakeland | Phase classification: P2 --> P3
Phase classification
|
ondansetron intravenous
7ms
Comparative Study Between Intrathecal (Dexmedetomidine Versus Fentanyl) (clinicaltrials.gov)
P=N/A, N=60, Completed, Sohag University
New trial
|
ondansetron intravenous
Share via
